MMR vaccine 2024

The provision of a vaccine to protect against measles, mumps and rubella, to be used as part of the national childhood immunisation programme. Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months. Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the suppliers.